ROIVANT SCIENCES LTD. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ROIVANT SCIENCES LTD. stock issued during period, value, stock options exercised for the quarter ending 2020-12-31 was $725.00K.
- ROIVANT SCIENCES LTD. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $119.00K.
- ROIVANT SCIENCES LTD. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $63.00K.
- ROIVANT SCIENCES LTD. stock issued during period, value, stock options exercised for fiscal 2022 was $412.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-03-31 | $412.00K 10-K · filed 2022-06-28 | |
| 2020-12-31 | $725.00K 10-Q · filed 2022-02-14 | |
| 2020-09-30 | $119.00K 10-Q · filed 2022-02-14 | |
| 2020-06-30 | $63.00K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |